Injectable vs Oral Administration for GERD Both injectable and oral administration routes deliver therapeutic effects for gastrointestinal applications, though each carries distinct advantages and considerations
(2021) have developed a validated questionnaire for subjective PEM assessment (Jason et al., 2021) which has been translated into multiple languages
Personal care composition for the treatment of acne and cutaneous disorders linked to hyperseborrhoea, comprising in a cosmetically acceptable medium at least one polymeric, ionic compound comprising imidazolium groups (imidazolium compound A), obtainable by reacting a) at least one a-dicarbonyl compound, b) at least one aldehyde, c) at least one amino compound having at least two primary amino groups, d) optionally an amino compound having only one primary amino group and e) at least one protic acid, and optionally subjecting the reaction product to an anion exchange, where the main chain of the at least one compound comprising imidazolium groups does not contain benzene rings, and where in the components a) and b) the aldehyde carbonyl groups may also be present as hemiacetal or acetal and the ketone carbonyl groups may also be present as hemiketal or ketal
Nature 403 , 4145 (2000)
Injectable BPC-157: Higher Absorption and Targeted Repair Typical range: 2001,000 mcg per day Common dose: 500 mcg per day Method: Subcutaneous (SubQ) injection near the injury site or abdomen Cycle: 26 weeks depending on injury severity Injectable BPC-157 offers the highest bioavailability and fastest results, especially for tendon, ligament, and muscle injuries
doi: 10.1016/j.nbd.2014.08.025 172 HuangD
